Alerts
Other content recommended for you
- Parents' experiences of newborn screening for genetic susceptibility to type 1 diabetes
- Primary prevention of neurological illness early in life
- What ethical and legal principles should guide the genotyping of children as part of a personalised screening programme for common cancer?
- Ethical issues in predictive genetic testing: a public health perspective
- Two faces of patient advocacy: the current controversy in newborn screening
- The new genetics: Genetic testing and public policy
- Effective screening leads to better outcomes in sickle cell disease
- Commercial predictive testing: the desirability of one overseeing body
- Newborn and childhood screening programmes: criteria, evidence, and current policy
- Co-design of patient information leaflets for germline predisposition to cancer: recommendations for clinical practice from the UK Cancer Genetics Group (UKCGG), Cancer Research UK (CRUK) funded CanGene-CanVar Programme and the Association of Genetic Nurse Counsellors (AGNC)